IRWD Price Targets and Analyst Ratings NASDAQ:IRWD
IRWD Forecast. What You Should Know.
IRWD Historical Ratings and Targets
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European... IRWD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.